article thumbnail

Hyman, Phelps & McNamara, P.C. (HP&M) is Pleased to Announce the Addition of Sara M. Keup as the new State Licensing Regulatory Expert for the Firm’s Licensing Practice

FDA Law Blog: Biosimilars

HP&M has been helping clients navigate the challenges of state licensing regulations for drugs, biologics, medical devices, OTCs, 503B outsourcing facilities, 503A pharmacies, foods, dietary supplements, cannabis, and wholesalers/distributors for many years. Keup has joined the firm to assist attorneys Karla L.

article thumbnail

$4.3 million awarded to advance transcription factor drugs

Drug Discovery World

Transcription factors are proteins that control every gene in a person’s genome by binding to DNA and flipping the on/off switches that govern gene expression. Talus Bio was also awarded a $2.0M When they go awry, they often drive cancer and other disease processes like diabetes, inflammatory diseases, and neurological conditions. “At

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Successful clinical trial for re-engineered Covid vaccine 

Drug Discovery World

UQ’s commercialisation company UniQuest has licensed the technology to Vicebio, which is progressing its use against respiratory pathogens such as respiratory syncytial virus, human metapneumovirus and parainfluenza viruses, according to Dr Chappell. I look forward to the continued progress of this cutting-edge technology”.

article thumbnail

World Tuberculosis Day 2024: New vaccines offer hope

Drug Discovery World

In another approach, in January 2024, the University of Oxford launched a study to compare whether giving Bacille Calmette-Guérin (BCG), the current licensed vaccine against TB, by inhalation provides better protection than injection into the skin. Governments worldwide must come together to combat this deadly disease.

Vaccine 130
article thumbnail

This week in drug discovery (4-8 September)  

Drug Discovery World

The top stories: UK joins Horizon Europe in “huge win” for research community Following lengthy negotiations, the UK government has announced that the UK will be participating as a fully associated member of Horizon Europe for the remaining life of the programme to 2027.

Drugs 130
article thumbnail

Three trends in the antibody-drug conjugate (ADC) market 

Drug Discovery World

The study forecast growth to 2022 and presented an in-depth strategic assessment of the antibody-drug conjugates, highlighting a number of influencing factors impacting or reinforcing market environment, including government policy, technological changes, and market drivers 4.

Marketing 245
article thumbnail

PFIZER AND THE MEDICINES PATENT POOL (MPP) SIGN LICENSING AGREEMENT FOR COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE TO EXPAND ACCESS IN LOW- AND MIDDLE-INCOME COUNTRIES

The Pharma Data

The agreement will enable MPP to grease fresh product and distribution of the investigational antiviral, pending nonsupervisory authorization or blessing, by grantingsub-licenses to good general drug manufacturers, with the thing of easing lesser access to the global population. This press release features multimedia.